ARCHIVES

IL-2 Trials Proliferate; Biotherapeutics Sees NCI Proposal As Vindication Of Its Policies

This article is from The Cancer Letter archive.

Vol. 13 No. 19 | May 8, 1987

Download PDF Visit The Full Archive

Related Articles

Lineberger Endows Chair To Honor Denman Hammond.

April 13, 2001

Clinical Research; Duke Received Several Warnings from OPRR, Letters Indicate

May 14, 1999

In Brief: Oldham To Head Biological Response Modifiers Program; Walter, Namovicz Named Acting Heads

August 8, 1980

Cyclamate Review Committee Starts Survey; Inventor Castigates NCI

September 12, 1975

Abstracts Of Papers From Gynecologic Oncology Conference

October 10, 1975

Congress Approves FY 1980 HEW Funds

November 23, 1979